Treatment of elderly Hodgkin's lymphoma patients. The experience of the Italian Lymphoma Intergroup.
Levis
Alessandro
A
Haematology Department, Ospedale SS Antonio e Biagio, Alessandria.
Pietrasanta
Daniela
D
Anselmo
Anna Paola
AP
Ambrosetti
Achille
A
Bertini
Marilena
M
D000284:Administration, Oral; D000367:Age Factors; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D003606:Dacarbazine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D015577:Geriatric Assessment; D006801:Humans; D007262:Infusions, Intravenous; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage; D011344:Procarbazine / Q000008:administration & dosage; D011379:Prognosis; D016019:Survival Analysis; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage
D001761:Bleomycin; D011344:Procarbazine; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin; D003520:Cyclophosphamide; D008942:Mitoxantrone